Related Experiment Video
Updated: Aug 13, 2025
06:54
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
6.1K
C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways
Olivia J Scully1, Sukanya Shyamasundar1, Ken Matsumoto2
1Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117594, Singapore.
International Journal of Molecular Sciences
|January 21, 2023
Summary
Complement component 1, q subcomponent binding protein (C1QBP) significantly impacts triple-negative breast cancer cell growth. Reducing C1QBP inhibits proliferation, while increasing it promotes cancer cell growth, suggesting C1QBP as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Breast carcinoma is a leading global cancer in women.
- Metastasis and drug resistance present significant challenges in breast cancer treatment.
- Complement component 1, q subcomponent binding protein (C1QBP) is implicated in breast cancer development.
Purpose of the Study:
- To investigate the role of C1QBP in the progression of triple-negative breast cancer.
- To determine the effect of C1QBP on cancer cell growth and proliferation in MDA-MB-231 cells.
Main Methods:
- Depletion and overexpression of C1QBP in MDA-MB-231 cells.
- Analysis of cell proliferation rates.
- Gene expression profiling and pathway analysis.
Main Results:
- C1QBP depletion led to decreased cell proliferation.
- C1QBP overexpression resulted in increased cell proliferation.
- C1QBP was found to regulate key signaling pathways involved in cell growth and survival.
Conclusions:
- C1QBP plays a crucial role in the progression of triple-negative breast cancer.
- Findings suggest C1QBP as a potential therapeutic target for breast cancer treatment.
- Further research into C1QBP-targeted therapies is warranted.
Related Concept Videos
01:19Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:31The Intrinsic Apoptotic Pathway
6.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
01:22PI3K/mTOR/AKT Signaling Pathway
3.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.8K